Effect of Methanol Leaf Extract of Annona senegalensis on Liver Function in Diethylnitrosamine-Induced Hepatocellular Carcinoma in Rats and Its Potential as an Antibacterial Agent
Article Sidebar
Page Numbers:
401-422
Digital Object Identifier:
10.58578/kijst.v2i3.7362
Viewed: 903 times
Downloaded: 141 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:
Isaac John Umaru1, Mary Athanasius Udoh2, Etah Hope Mona3, Mosugu Ovayoza Omolara4, Ogar Fonne Okang5, Ingwu Joseph Akem6, Akafa Andes Tansaba7, Shadrach Philip8, Otashu Kenneth Frank9 
Copyright :
Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
Hepatocellular carcinoma (HCC) is among the most prevalent and deadly cancers globally, with limited treatment options and poor prognosis in advanced stages. This study evaluated the therapeutic potential of methanol leaf extract of Annona senegalensis against diethylnitrosamine (DEN)-induced HCC in Wistar rats and investigated its antibacterial properties. Thirty-six male albino rats were allocated into six groups: Group I (normal control) received no treatment; Group II (negative control) was induced with HCC using DEN (50 mg/kg b.w., intraperitoneally) weekly for three weeks without therapy; Group III (positive control) received DEN followed by silymarin (100 mg/kg b.w.); while Groups IV, V, and VI received DEN followed by A. senegalensis extract at 200, 400, and 600 mg/kg b.w., respectively, administered orally for 14 days. Biochemical analysis showed that the extract significantly (p < 0.05) ameliorated DEN-induced hepatotoxicity, with the 400 mg/kg dose most effective in reducing AST (48.71 ± 1.21 IU/L) and ALT (20.74 ± 1.06 IU/L) compared to the negative control (69.52 ± 0.88 IU/L and 54.97 ± 1.54 IU/L, respectively). Hepatic synthetic function was restored, as indicated by increased total protein (6.37 ± 0.13 g/L) and albumin (5.11 ± 0.10 g/L). Histopathological analysis confirmed marked architectural recovery with reduced necrosis and inflammatory infiltration. The extract also demonstrated significant antibacterial activity, exhibiting dose-dependent inhibition zones against Gram-positive (Staphylococcus aureus, Bacillus subtilis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria, with effects comparable to standard antibiotics. These findings suggest that A. senegalensis leaf extract exerts hepatoprotective effects—likely through antioxidant, anti-inflammatory, and antiproliferative mechanisms—while also offering broad-spectrum antimicrobial benefits. The 400 mg/kg dose emerged as the most effective, highlighting its promise as a cost-effective complementary therapy for managing HCC and bacterial infections, particularly in resource-constrained settings. Further research should focus on isolating and characterizing the bioactive compounds and elucidating their mechanisms of action.
Citation Metrics:
Downloads
Article Details
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.